After treating ccRCC cells stably overexpressing CYP1B1 and SU-R ccRCC cells with CYP1B1 knockdown with CHX, we observed significant changes in HIF2α protein stability. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.